Elaris FlexCo ("Elaris"), an Austrian biotechnology company developing vaccines against serious bacterial infections, today announced that it has entered into an asset purchase agreement with Matrivax ...

Novavax, Inc. (Nasdaq: NVAX) today announced its financial results and operational highlights for the first quarter ended March 31, 2026.

Novavax (NVAX) shares added ~6% in the premarket on Wednesday after the COVID-19 vaccine maker well exceeded Street forecasts with its Q1 financials, thanks to a licensing deal with Pfizer (PFE) ...

Total revenue of $140 million in the first quarter of 2026 Pfizer agreement announced in January for non-exclusive license to utilize Matrix-M® in two infectious ...

A review of microscopic colitis, a chronic, intermittent inflammatory bowel disease that predominantly affects older women and typically presents with frequent watery, non-bloody stools.

Please provide your email address to receive an email when new articles are posted on . A 4-week vancomycin pulse and taper regimen may be a safe and effective strategy to delay or prevent ...

Indian billionaire Dilip Shanghvi’s plans to expand his healthcare empire in the U.S., the hantavirus outbreak on a cruise ...

SAN ANTONIO - A group of frontline hospital workers who often go unseen in day-to-day patient care was recognized Friday at University Health San Antonio. LIV Process, a biotechnology research company ...

Methodology that is not complete, as well as discrepancies regarding the proposed mode of action of lipoxin A4, are significant weaknesses.

Probiotic supplements might not have any effect on health if they aren't the right strains or if they die before reaching the ...

Visiting any medical facility is nightmare fuel for millions of Americans, and a lurking bacteria threatens to strike the ...